Skip to content
TrialScanner

NCT02585869

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Phase 2CompletedMTVALead

Registry record

Lead sponsor
NeuroBo Pharmaceuticals Inc.
Conditions
Hypercholesterolemia; Hypertriglyceridemia
Primary completion
Jun 2001Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02585869 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02585869: Efficacy and Safety of... | TrialScanner